Cencora, Inc. (BMV:COR)

Mexico flag Mexico · Delayed Price · Currency is MXN
6,733.22
+173.09 (2.64%)
At close: Nov 18, 2025
35.75%
Market Cap 1.19T
Revenue (ttm) 5.89T
Net Income (ttm) 28.51B
Shares Out n/a
EPS (ttm) 146.00
PE Ratio 41.90
Forward PE 19.14
Dividend 43.29 (0.64%)
Ex-Dividend Date Nov 14, 2025
Volume 62
Average Volume 331
Open 6,733.22
Previous Close 6,560.13
Day's Range 6,733.22 - 6,733.22
52-Week Range 4,924.22 - 6,733.22
Beta n/a
RSI 78.28
Earnings Date Feb 4, 2026

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, ... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1871
Employees 51,000
Stock Exchange Mexican Stock Exchange
Ticker Symbol COR
Full Company Profile

Financial Performance

In 2025, Cencora's revenue was $321.33 billion, an increase of 9.31% compared to the previous year's $293.96 billion. Earnings were $1.55 billion, an increase of 2.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.